Nicolet Bankshares’s AbbVie ABBV Stock Holding History

Nicolet Bankshares’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7M	Sell	42,391 -173	-0.4%	-$37.2K	0.34%	56
2026 Q1	$9.24M	Buy	42,564 +36,695	+625%	+$8.14M	0.34%	56
2025 Q4	$1.34M	Buy	5,869 +161	+3%	+$36.7K	0.21%	75
2025 Q3	$1.32M	Buy	5,708 +296	+5%	+$60.3K	0.21%	72
2025 Q2	$1M	Sell	5,412 -34	-0.6%	-$6.32K	0.17%	87
2025 Q1	$1.14M	Buy	5,446 +150	+3%	+$29.2K	0.23%	73
2024 Q4	$941K	Sell	5,296 -21	-0.4%	-$3.86K	0.22%	91
2024 Q3	$1.05M	Sell	5,317 -55	-1%	-$10.3K	0.25%	85
2024 Q2	$921K	Sell	5,372 -65	-1%	-$10.8K	0.23%	92
2024 Q1	$990K	Buy	5,437 +34	+0.6%	+$5.86K	0.24%	95
2023 Q4	$837K	Buy	5,403 +378	+8%	+$55.1K	0.23%	99
2023 Q3	$749K	Hold	5,025	–	–	0.23%	93
2023 Q2	$677K	Sell	5,025 -989	-16%	-$145K	0.19%	103
2023 Q1	$958K	Buy	6,014 +837	+16%	+$128K	0.31%	63
2022 Q4	$837K	Sell	5,177 -498	-9%	-$76.4K	0.29%	68
2022 Q3	$762K	Sell	5,675 -411	-7%	-$59K	0.22%	81
2022 Q2	$932K	Buy	6,086 +380	+7%	+$58.1K	0.24%	77
2022 Q1	$925K	Buy	5,706 +843	+17%	+$122K	0.2%	84
2021 Q4	$658K	Hold	4,863	–	–	0.15%	100
2021 Q3	$525K	Sell	4,863 -1,941	-29%	-$222K	0.14%	116
2021 Q2	$766K	Sell	6,804 -350	-5%	-$39.4K	0.2%	84
2021 Q1	$774K	Buy	7,154 +1,782	+33%	+$191K	0.21%	80
2020 Q4	$576K	Sell	5,372 -43	-0.8%	-$4.13K	0.18%	95
2020 Q3	$474K	Buy	5,415 +795	+17%	+$74.8K	0.16%	103
2020 Q2	$454K	Buy	4,620 +366	+9%	+$32.2K	0.17%	101
2020 Q1	$324K	Hold	4,254	–	–	0.15%	117
2019 Q4	$377K	Buy	4,254 +40	+0.9%	+$3.32K	0.14%	132
2019 Q3	$319K	Sell	4,214 -1,076	-20%	-$73.8K	0.13%	138
2019 Q2	$385K	Buy	5,290 +265	+5%	+$20.8K	0.16%	121
2019 Q1	$405K	Buy	5,025 +13	+0.3%	+$1.06K	0.17%	118
2018 Q4	$462K	Hold	5,012	–	–	0.22%	86
2018 Q3	$474K	Buy	5,012 +203	+4%	+$19.3K	0.19%	103
2018 Q2	$446K	Buy	4,809 +215	+5%	+$21K	0.19%	100
2018 Q1	$435K	Sell	4,594 -7	-0.2%	-$769	0.19%	108
2017 Q4	$445K	Sell	4,601 -40	-0.9%	-$3.77K	0.19%	110
2017 Q3	$412K	Sell	4,641 -395	-8%	-$30.1K	0.18%	110
2017 Q2	$365K	Buy	5,036 +70	+1%	+$4.71K	0.17%	116
2017 Q1	$324K	Sell	4,966 -637	-11%	-$40K	0.17%	115
2016 Q4	$351K	Sell	5,603 -1,150	-17%	-$70.2K	0.19%	101
2016 Q3	$426K	Buy	6,753 +200	+3%	+$12.9K	0.25%	93
2016 Q2	$406K	Hold	6,553	–	–	0.27%	84
2016 Q1	$374K	Hold	6,553	–	–	0.27%	79
2015 Q4	$360K	Buy	+6,553	New	+$377K	0.36%	71

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nicolet Bankshares's ABBV Position: Q2 2026 in Review

Nicolet Bankshares reduced its AbbVie (ABBV) stake by 0.41% in Q2 2026, selling an estimated $37.2K and leaving 42,391 shares worth $10.7M. The position accounts for 0.34% of the portfolio, ranked #56.

Nicolet Bankshares first reported a position in ABBV in Q4 2015 and has held it in 43 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nicolet Bankshares held 42,391 shares of AbbVie worth $10.7M as of Q2 2026.
Nicolet Bankshares sold 173 AbbVie shares in Q2 2026, an estimated $37.2K.
AbbVie made up 0.34% of Nicolet Bankshares's portfolio in Q2 2026, its #56 holding.
Nicolet Bankshares first reported a position in AbbVie in Q4 2015 and has held it in 43 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.